Joined: Jul 09, 2006 Posts: 642 Location: Manassas, Virginia, USA
Posted: Sat Jan 06, 2018 5:31 pm Post subject: SolveBio and II SBIR Grant for Variant Analysis!
SolveBio has been awarded a $1.5 million Phase II Small Business Innovation Research grant from the National Institutes of Health to continue development of a cloud-based genetic variation analysis and visualization system called Variant Explorer.
According to SolveBio, Variant Explorer enables researchers to identify sequenced variants that correlate with drug resistance or response, determine the molecular functional consequences of significant variants found in patients, and explore the relevant clinical and experimental evidence for understanding a given variant.
"This new NIH grant will allow us to continue to work with our biopharma partners to develop analytics tools, algorithms, and interfaces to harness new technologies, especially NGS and liquid biopsy, to achieve this vision and accelerate precision medicine-based therapeutic development," SolveBio CEO Mark Kaganovich said in a statement.
January 2018 _________________ Be Joyful, Heal Yourself and Age Gracefully!
You cannot post new topics in this forum You cannot reply to topics in this forum You cannot edit your posts in this forum You cannot delete your posts in this forum You cannot vote in polls in this forum